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tive  tumor  suppressor  genes, 

















Analysis of DNA hypomethylation, degree of genomic instability, and CpG hypermethylation in normal livers 
(NL), nonneoplastic surrounding liver tissues (ST), and HCC with shorter (subclass A) and longer (subclass B) 
survival rate. (A) As a measure of genome-wide hypomethylation, the incorporation of [3H]dCTP into DNA 
was assessed after treatment with HpaII endonuclease, cutting only nonmethylated sites. In nontumorous 
surrounding livers, global DNA hypomethylation was significantly higher than in normal livers. Genomic 
hypomethylation progressively increased from nonneoplastic surrounding livers to HCC. Liver tumors with 
poor prognosis displayed the highest levels of DNA hypomethylation. (B) Degree of genomic alterations as 
detected by RAPD analysis. The level of genomic alterations was significantly higher in subclass A than in 
subclass B HCC (P = 7.8 × 10–8). (C) Correlation between DNA hypomethylation and genomic alterations. 
r2 = 0.945; P < 0.001. (D) To determine CpG regional hypermethylation, DNA was pretreated with BssHII 
endonuclease. Since BssHII cuts only unmethylated sites, the lower [3H]dCTP incorporation indicates 
fewer unmethylated (cleaved) CpG sites and, therefore, a higher de novo methylation. CpG methylation 
levels were highest in HCC, particular in tumors of subclass A.
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CpG methylation positively correlates 
with HCC development and progression.  

























Summary of promoter hypermethylation frequency in subclass A and B HCC as detected by methyla-
tion-specific PCR. Black and gray boxes indicate the presence or absence of promoter hypermethyl-
ation, respectively. Note the significantly higher number of genes affected by methylation in subclass 
A HCC. Only genes that were affected by promoter methylation in at least 1 sample are shown.
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Epigenetic silencing of multiple tumor suppressor genes maintains activa-































Methylation index in HCC from patients with shorter (subclass A) and 
longer (subclass B) survival. Methylation index (or mean frequency of 
methylation) was defined as the ratio between the numbers of meth-
ylated genes to total number of examined genes in each sample. 
(A) Methylation index was highest in subclass A HCC. (B) Methyla-
tion index negatively correlated with the length of patient’s survival 
(r2 = 0.7387; P < 0.0001).
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B  and C).  In  contrast,  downregulation of  SPRY1 
and SPRY2 in subclass A HCC was paralleled by low 




































Activation of Ras and Ras downstream effectors in normal livers, nonneoplastic sur-
rounding tissues, and HCC. Activity of Ras (A), ERK (B), AKT (C), and Ral A (D) 
progressively increased from nontumorous surrounding livers to HCC, reaching the 
highest levels in subclass A HCC. Of note, the Ras downstream effector Ral A was 
active mostly in subclass A HCC. Proteins levels of total Ras (Pan Ras), ERK, AKT, 
and Ral A are shown to ensure equal protein loading. MBP, myelin basic protein; 
pGSK-3β, phospho–glycogen synthase kinase–3β.
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Representative Western blot and immunoprecipitation analyses of Ras inhibitors and Ras 
downstream effectors in normal livers, nonneoplastic surrounding tissues, and HCC. (A) 
Downregulation of EGFR inhibitors SOCS4 and SOCS5 resulted in increased EGFR levels, 
EGFR activation, and low EGFR/SOCS5 complexes in subclass A HCC. (B) Downregulation 
of SPRY1, -2, and -4 led to FGF receptor (FGFR) upregulation and increased FGF-medi-
ated Ras signaling activation, as shown by a decrease in SPRY1/GRB2 and SPRY2/GRB2 
complexes and increase in FRS2/GRB2 complexes in subclass A HCC. (C) In contrast, sub-
class B HCC showed elevated levels of both total (t) and membranous (m) SPRY1 and -2, 
leading to SPRY1 and -2 activation by tyrosine phosphorylation, increase in SPRY1/GRB2 
and SPRY2/GRB2 complexes, and decrease in FRS2/GRB2 complexes (C). (D) DAB2 was 
downregulated in subclass A HCC, with consequent upregulation of c-Fos, Src, and ILK.
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Representative Western blot and immuno-
precipitation (IP) analyses of Ras proangio-
genic targets (A) and inhibitors of Ras-driven 
angiogenesis (B). Upregulation of HIF-1α, 
VEGF, and IL-8 (A) was associated with high 
HIF-1α/ARNT complexes, low levels of HIF-1α 
inhibitors (IGFBP3, BNIP3, BNIP3L, and 
EGLN2), and low EGLN2/HIF-1α complexes in 
subclass A HCC (B). (C) Suppression of Ras 
downstream effectors MEK (UO126 [UO]) and 
AKT (LY294002 [LY]) led to downregulation of 
HIF-1α, VEGF, and IL-8 in Focus hepatoma 
cell lines. (D) Reactivation of HIF-1α inhibi-
tors and EGLN2 by Zebularine (Zeb) reduced 
HIF-1α, VEGF, and IL-8 expression in Focus 
hepatoma cell lines. Equivalent results were 
obtained in SNU-387 and 7703 hepatoma cell 
lines (data not shown).
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Clinicopathological features of HCC patients
Variable	 No.	of	cases
No. of patients 60
 Male 49
 Female 11




 Alcohol use 4









 <5 cm 42
 >5 cm 18
Survival
 Subclass A (n = 30), mean ± SD (mo) 15.8 ± 5.75
 Subclass B (n = 30), mean ± SD 54 ± 12.37
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centromeric  satellite  regions  during  human 

























































dermal growth factor signaling. Proc. Natl. Acad. Sci. 
U. S. A. 102:2328–2333.
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